Gainers
- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
- Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 58.4% to settle at $1.22. Clarus Therapeutics recently reported initiation of Phase 4 trial of JATENZO for treatment of hypogonadal men with chronic kidney disease.
- Yumanity Therapeutics, Inc. (NASDAQ:YMTX) shares surged 58% to settle at $1.77.
- Ipsidy Inc. (NASDAQ:AUID) gained 54.1% to settle at $4.67. authID.ai reported 2021 revenue of $2.3 million, up from $2.1 million year over year.
- BitNile Holdings, Inc. (NYSE:NILE) gained 48.6% to close at $0.83. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-commerce operations.
- United Time Technology Co., Ltd. (NASDAQ:UTME) shares climbed 44.8% to close at $2.78 following a 12% surge on Friday.
- Dermata Therapeutics, Inc. (NASDAQ:DRMA) surged 44% to settle at $1.44.
- Cyren Ltd. (NASDAQ:CYRN) jumped 43.2% to settle at $9.08 following a statement from U.S. President Joe Biden calling for increased cybersecurity measures.
- PainReform Ltd. (NASDAQ:PRFX) surged 39.6% to close at $1.55. PainReform recently reported a FY21 net loss of $7.2 million.
